Research progress on the effect of GLP-1RA on cardiovascular diseases

VernacularTitle:GLP-1RA对心血管疾病作用的研究进展
Author: Jing-Yi ZHANG ¹ ; Li-Jun JIAO ; Xin-Yan WANG
Author Information

1. 哈尔滨医科大学附属第二医院呼吸内科,黑龙江哈尔滨 150081
Keywords: Cardiovascular diseases; Diabetes mellitus,type 2; Glucagon-like peptide-1 receptor agonists
From: Chinese Journal of cardiovascular Rehabilitation Medicine 2024;33(3):364-367
CountryChina
Language:Chinese
Abstract: Type 2 diabetes mellitus(T2DM)is associated with an increased incidence rate of cardiovascular disease(CVD).In recent years,numerous cardiovascular outcome trials(CVOT)have confirmed the definite cardiovascu-lar benefits of glucagon-like peptide-1 receptor agonists(GLP-1RA).In this paper,the existing GLP-1RAs were summarized,with special attention to their clinical impact on cardiovascular disease risk factors and mechanism of action,so as to provide theoretical basis for clinical prevention and treatment of CVD,and provide more treat-ment options not only for T2DM patients complicated with CVD,but also for non-diabetic patients.